Bio-Techne Corp (TECH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bio-Techne Corp (TECH) has a cash flow conversion efficiency ratio of 0.041x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($82.41 Million) by net assets ($2.01 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bio-Techne Corp - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how Bio-Techne Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Bio-Techne Corp (TECH) total liabilities for a breakdown of total debt and financial obligations.
Bio-Techne Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Techne Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Longfor Group Holdings Limited
F:RLF
|
0.027x |
|
GDS Holdings Limited
F:G40
|
0.027x |
|
Founder Technology Group Co Ltd
SHG:600601
|
0.084x |
|
SalMar ASA
OL:SALM
|
0.180x |
|
Guangzhou Automobile Group Co Ltd Class A
SHG:601238
|
0.003x |
|
National Fuel Gas Company
NYSE:NFG
|
0.077x |
|
Infore Environment Technology Group Co Ltd
SHE:000967
|
-0.010x |
|
Mytilineos S.A
AT:MYTIL
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Bio-Techne Corp (1990–2025)
The table below shows the annual cash flow conversion efficiency of Bio-Techne Corp from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see Bio-Techne Corp market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $1.92 Billion | $287.56 Million | 0.150x | +3.70% |
| 2024-06-30 | $2.07 Billion | $298.98 Million | 0.145x | +11.71% |
| 2023-06-30 | $1.97 Billion | $254.39 Million | 0.129x | -32.35% |
| 2022-06-30 | $1.70 Billion | $325.27 Million | 0.191x | -14.68% |
| 2021-06-30 | $1.57 Billion | $352.16 Million | 0.224x | +50.85% |
| 2020-06-30 | $1.38 Billion | $205.22 Million | 0.149x | -4.65% |
| 2019-06-30 | $1.17 Billion | $181.62 Million | 0.156x | -1.30% |
| 2018-06-30 | $1.08 Billion | $170.37 Million | 0.158x | +4.64% |
| 2017-06-30 | $950.83 Million | $143.45 Million | 0.151x | -7.80% |
| 2016-06-30 | $879.28 Million | $143.87 Million | 0.164x | -0.56% |
| 2015-06-30 | $846.93 Million | $139.36 Million | 0.165x | -4.32% |
| 2014-06-30 | $795.26 Million | $136.76 Million | 0.172x | +2.65% |
| 2013-06-30 | $737.54 Million | $123.56 Million | 0.168x | -10.85% |
| 2012-06-30 | $674.44 Million | $126.75 Million | 0.188x | -13.40% |
| 2011-06-30 | $586.12 Million | $127.19 Million | 0.217x | -2.13% |
| 2010-06-30 | $501.79 Million | $111.26 Million | 0.222x | -9.08% |
| 2009-06-30 | $456.48 Million | $111.32 Million | 0.244x | +3.02% |
| 2008-06-30 | $487.13 Million | $115.32 Million | 0.237x | +14.48% |
| 2007-06-30 | $437.65 Million | $90.50 Million | 0.207x | -17.77% |
| 2006-06-30 | $340.35 Million | $85.59 Million | 0.251x | -9.50% |
| 2005-06-30 | $267.87 Million | $74.43 Million | 0.278x | +26.07% |
| 2004-06-30 | $297.43 Million | $65.55 Million | 0.220x | -3.58% |
| 2003-06-30 | $236.62 Million | $54.09 Million | 0.229x | +70.63% |
| 2002-06-30 | $206.52 Million | $27.67 Million | 0.134x | -48.67% |
| 2001-06-30 | $177.66 Million | $46.37 Million | 0.261x | -4.90% |
| 2000-06-30 | $141.15 Million | $38.74 Million | 0.274x | -6.45% |
| 1999-06-30 | $96.80 Million | $28.40 Million | 0.293x | -7.79% |
| 1998-06-30 | $63.80 Million | $20.30 Million | 0.318x | +22.44% |
| 1997-06-30 | $48.10 Million | $12.50 Million | 0.260x | +3.15% |
| 1996-06-30 | $38.90 Million | $9.80 Million | 0.252x | +1.81% |
| 1995-06-30 | $29.50 Million | $7.30 Million | 0.247x | -9.66% |
| 1994-06-30 | $23.00 Million | $6.30 Million | 0.274x | +8.35% |
| 1993-06-30 | $17.80 Million | $4.50 Million | 0.253x | -27.40% |
| 1992-06-30 | $11.20 Million | $3.90 Million | 0.348x | +21.88% |
| 1991-06-30 | $6.30 Million | $1.80 Million | 0.286x | +19.48% |
| 1990-06-30 | $4.60 Million | $1.10 Million | 0.239x | -- |
About Bio-Techne Corp
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various asp… Read more